156 related articles for article (PubMed ID: 2139540)
1. In vivo phosphorus-31 spectroscopic imaging in patients with global myocardial disease.
Schaefer S; Gober JR; Schwartz GG; Twieg DB; Weiner MW; Massie B
Am J Cardiol; 1990 May; 65(16):1154-61. PubMed ID: 2139540
[TBL] [Abstract][Full Text] [Related]
2. Nuclear magnetic resonance spectroscopy of excised human hearts.
Brunotte F; Peiffert B; Escanye JM; Pinelli G; Zamorano J; Walker PM; Robert J; Villemot JP
Br Heart J; 1992 Sep; 68(3):272-5. PubMed ID: 1389757
[TBL] [Abstract][Full Text] [Related]
3. Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy.
Neubauer S; Horn M; Cramer M; Harre K; Newell JB; Peters W; Pabst T; Ertl G; Hahn D; Ingwall JS; Kochsiek K
Circulation; 1997 Oct; 96(7):2190-6. PubMed ID: 9337189
[TBL] [Abstract][Full Text] [Related]
4. High-energy phosphate metabolism of the myocardium in normal subjects and patients with various cardiomyopathies--the study using ECG gated MR spectroscopy with a localization technique.
Masuda Y; Tateno Y; Ikehira H; Hashimoto T; Shishido F; Sekiya M; Imazeki Y; Imai H; Watanabe S; Inagaki Y
Jpn Circ J; 1992 Jun; 56(6):620-6. PubMed ID: 1625368
[TBL] [Abstract][Full Text] [Related]
5. Altered myocardial high-energy phosphate metabolites in patients with dilated cardiomyopathy.
Hardy CJ; Weiss RG; Bottomley PA; Gerstenblith G
Am Heart J; 1991 Sep; 122(3 Pt 1):795-801. PubMed ID: 1877457
[TBL] [Abstract][Full Text] [Related]
6. The relationship between plasma BNP level and the myocardial phosphocreatine/adenosine triphosphate ratio determined by phosphorus-31 magnetic resonance spectroscopy in patients with dilated cardiomyopathy.
Chida K; Otani H; Kohzuki M; Saito H; Kagaya Y; Takai Y; Takahashi S; Yamada S; Zuguchi M
Cardiology; 2006; 106(3):132-6. PubMed ID: 16636542
[TBL] [Abstract][Full Text] [Related]
7. Normal and diffusely abnormal myocardium in humans: functional and metabolic characterization with P-31 MR spectroscopy and cine MR imaging.
Auffermann W; Chew WM; Wolfe CL; Tavares NJ; Parmley WW; Semelka RC; Donnelly T; Chatterjee K; Higgins CB
Radiology; 1991 Apr; 179(1):253-9. PubMed ID: 2006287
[TBL] [Abstract][Full Text] [Related]
8. Absolute concentrations of high-energy phosphate metabolites in normal, hypertrophied, and failing human myocardium measured noninvasively with (31)P-SLOOP magnetic resonance spectroscopy.
Beer M; Seyfarth T; Sandstede J; Landschütz W; Lipke C; Köstler H; von Kienlin M; Harre K; Hahn D; Neubauer S
J Am Coll Cardiol; 2002 Oct; 40(7):1267-74. PubMed ID: 12383574
[TBL] [Abstract][Full Text] [Related]
9. Metabolic response of the human heart to inotropic stimulation: in vivo phosphorus-31 studies of normal and cardiomyopathic myocardium.
Schaefer S; Schwartz GG; Steinman SK; Meyerhoff DJ; Massie BM; Weiner MW
Magn Reson Med; 1992 Jun; 25(2):260-72. PubMed ID: 1614310
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of altered myocardial high energy phosphate metabolism in patients on maintenance dialysis using phosphorus-31 magnetic resonance spectroscopy.
Tagami T; Sakuma H; Matsumura K; Takeda K; Mori S; Takeuchi T; Nakano T
Invest Radiol; 1998 Mar; 33(3):171-6. PubMed ID: 9525756
[TBL] [Abstract][Full Text] [Related]
11. [In-vivo 31P-NMR-spectroscopy in patients with dilated cardiomyopathy].
Kaiser WA; Pauleit D; Träber F; Köhler U; Reiser M
Rofo; 1992 Nov; 157(5):458-65. PubMed ID: 1421186
[TBL] [Abstract][Full Text] [Related]
12. Myocardial high-energy phosphate metabolism in patients with stable chronic dilated cardiomyopathy under a dobutamine-induced prolonged mild workload.
Nanbu T; Nakakoshi T; Yonezawa K; Kitabatake A
Am Heart J; 1999 Oct; 138(4 Pt 1):641-5. PubMed ID: 10502208
[TBL] [Abstract][Full Text] [Related]
13. Cardiac metabolism in patients with dilated and hypertrophic cardiomyopathy: assessment with proton-decoupled P-31 MR spectroscopy.
de Roos A; Doornbos J; Luyten PR; Oosterwaal LJ; van der Wall EE; den Hollander JA
J Magn Reson Imaging; 1992; 2(6):711-9. PubMed ID: 1446116
[TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance spectroscopy in human cardiomyopathies.
Schaefer S
J Cardiovasc Magn Reson; 2000; 2(2):151-7. PubMed ID: 11545132
[TBL] [Abstract][Full Text] [Related]
15. 31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease. Altered cardiac high-energy phosphate metabolism in heart failure.
Neubauer S; Krahe T; Schindler R; Horn M; Hillenbrand H; Entzeroth C; Mader H; Kromer EP; Riegger GA; Lackner K
Circulation; 1992 Dec; 86(6):1810-8. PubMed ID: 1451253
[TBL] [Abstract][Full Text] [Related]
16. Nuclear magnetic resonance imaging-guided phosphorus-31 spectroscopy of the human heart.
Schaefer S; Gober J; Valenza M; Karczmar GS; Matson GB; Camacho SA; Botvinick EH; Massie B; Weiner MW
J Am Coll Cardiol; 1988 Dec; 12(6):1449-55. PubMed ID: 3192842
[TBL] [Abstract][Full Text] [Related]
17. Effects of exercise training on myocardial energy metabolism and ventricular function assessed by quantitative phosphorus-31 magnetic resonance spectroscopy and magnetic resonance imaging in dilated cardiomyopathy.
Beer M; Wagner D; Myers J; Sandstede J; Köstler H; Hahn D; Neubauer S; Dubach P
J Am Coll Cardiol; 2008 May; 51(19):1883-91. PubMed ID: 18466804
[TBL] [Abstract][Full Text] [Related]
18. [31P magnetic-resonance spectroscopy in cardiac diseases].
Mazaev VV; Stukalova OV; Ternovoĭ SK; Chazova IE
Kardiologiia; 2012; 52(3):67-73. PubMed ID: 22839445
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the metabolism of high energy phosphates in patients with Chagas' disease.
Leme AM; Salemi VM; Parga JR; Ianni BM; Mady C; Weiss RG; Kalil-Filho R
Arq Bras Cardiol; 2010 Aug; 95(2):264-70. PubMed ID: 20676586
[TBL] [Abstract][Full Text] [Related]
20. Feasibility of rapid-sequence 31P magnetic resonance spectroscopy in cardiac patients.
Chida K; Otani H; Saito H; Nagasaka T; Kagaya Y; Kohzuki M; Zuguchi M; Shirato K
Acta Radiol; 2005 Jul; 46(4):386-90. PubMed ID: 16134315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
